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or many of us, keeping up with
the literature poses a never-
ending challenge. We rely on
word of mouth, ‘‘news and views,’’
journal clubs, or E-mail alerts to stay
abreast of our ﬁeld. But the media are
also potent arbiters of scientiﬁc
advances. And in the realm of genetics,
I can think of no better source than
Nicholas Wade of the New York Times.
What I like about reading Wade is
that he gets right to the point—
describing the discovery at hand in the
ﬁrst paragraph, yet roping me in for
the full story. He’s clear, crisp, and
rarely misses the mark.
When visiting my father in rural
Pennsylvania recently, I had the
opportunity of interviewing Wade in
situ at the venerable Times ofﬁce
building in Manhattan. The bus
deposited me at the Port Authority Bus
Terminal at the corner of 8th Avenue
and 41st Street in blistering heat. I
quickly walked two blocks north and
turned the corner at 43rd Street to
encounter the massive Times structure
looming above, its signature globe
lights forming a beacon to a set of
revolving doors. I entered beneath the
motto ‘‘All the news that’s ﬁt to print,’’
registered at the front desk, and took
the elevator up to the fourth ﬂoor,
where I was met by Wade.
Wade gave me a quick accounting of
the enormous newsroom, which at that
level, houses science and arts reporters
and editors. On passing through a maze
of cubicles, he commented that it
looked just like any ofﬁce building. ‘‘A
lot messier,’’ I rejoined, as untidy stacks
of papers were strewn everywhere.
Inside a small conference room, I
ﬁddled with my tape recorder,
cognizant of a pro watching this
neophyte. I looked across to a British
man with a soft voice, lively blue eyes,
and a puckish grin. He wasted no time
turning the tables on me by asking,
‘‘Will the questions get too pointed?’’
‘‘No, they won’t,’’ I replied. ‘‘I’m very
sweet.’’
‘‘Your ﬁrst mistake,’’ said he. And
thus we began.
Jane Gitschier: How do you describe
your beat?
Nicholas Wade: We’re a small
department, and the boundaries of the
beats are ﬂexible. By and large, I cover
whatever I’m interested in. I manage to
keep out of others’ way because I keep
close to the frontiers of biological
research, particularly genetics and
molecular biology, and no one else has
quite the same interests. Many of my
colleagues write about medicine, for
example, but I write only about things
that are perfectly useless, given that it
takes some time to translate basic
research into anything practical.
It’s one of the challenges we have as a
science section—to get people
interested in things that are of purely
intellectual consequence.
Gitschier: How do you envision your
readership?
Wade: As a general policy, the
newspaper is addressed to the
intelligent and informed reader, but it’s
always with the idea of bringing news.
We’re not in the business of education.
People can ﬁnd general information
from a dictionary or the Internet.
For the science section, although we
should have the same readership as the
main newspaper, I assume that readers
have a certain amount of scientiﬁc
knowledge or interest, and, of course,
many readers of the section are
scientists. So we can sometimes put in
more technical detail than we would in
the main newspaper.
Gitschier: The Times doesn’t do a
readership poll to ask how many people
are actually reading Nicholas Wade’s
articles?
Wade: Ourbusinessofﬁcedoesdothose
polls, but they are kept secret from us.
That’s with the idea that the content of
the newspaper should not be driven by
polls or market results but rather by
what the editors think is important.
Gitschier: How long have you worked
for the New York Times?
Wade: Longer than I like to think! I
came in 1981.
I was on the news section of Science,
and before that with Nature. At both
journals, I was mostly concerned with
political stories that affected science. I
found I had a great deal to learn when I
came back to science writing.
Gitschier: And before that, were you a
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writer, but I was interested in science,
so I read science at university
[Cambridge], though without any
intention of becoming a scientist. I
didn’t plan to be a science writer
either, but the two things came
together. I got a job with Nature in
London when I was quite young, and
was sent off to the Washington ofﬁce
that Nature had just set up. After a few
years, Science asked me to join them. I
thought it would be fun to work with an
American company. I worked for them
for about ten years.
The Times asked me to join them as
an editorial writer to cover science,
technology, and medicine, and I did
that for about ten years. Editorial
writing is great fun, but it’s rather a
limited art form.
Gitschier: Can you describe editorial
writing?
Wade: Editorials are unsigned pieces
[on the editorial page] because they are
intended to be the voice of the paper.
That anonymity may give the writer’s
words extra authority, but the
disadvantage is that you lose your
byline, unfortunately. So as a writer,
you essentially disappear from public
view.
The only exception is when you
advocate a position that the editors do
not think should be the position of the
paper. The piece is then called an
editorial notebook and appears with
your byline to make clear it’s just your
opinion, not theirs.
After writing editorials for ten years,
I became science editor. That, too, is a
job that deprives you of a byline
because there is almost no time to
write. The science editors handle both
the science stories in the daily paper,
and those in the weekly science section.
As an editor, you get to see how the
paper works, which is of great interest,
but you cease reporting, and spend a
lot of time improving other people’s
stories and attending meetings.
One of the great things about being a
writer, particularly an editorial writer,
is that you get to know a lot. The whole
world comes through New York, and
many people want to talk to the Times.
Often the reporters and editors on the
main paper are too busy to see them, so
they end up talking to the editorial
board, where the pressure of work is
much less. So even if you don’t cover
foreign policy or defense, you can get
to meet the leaders in these ﬁelds by
sitting in on your colleagues’ meetings.
But when I became an editor, I found
I was one step back from the front line
of the news. Being unable to research
or write anything, my intellectual
capital dwindled fast, until I began to
feel I had gone from knowing almost
everything about the world as an
editorial writer to knowing almost
nothing [as an editor]. On a newspaper,
the most interesting job is reporting. I
went back to writing as a reporter ﬁve
or six years ago.
Gitschier: I’m interested in the process
that you undergo in developing a story.
First, how do you discover what’s out
there?
Wade: Mostly, we ﬁnd out through the
main journals that we watch. Most of
them have now become sophisticated
in preparing what they call ‘‘tip sheets,’’
or weekly lists of their most
newsworthy articles, which are seen as a
marketing tool for journals. They’ll say
to potential authors, ‘‘Send us your
paper, and we’ll get you mentioned in
the press.’’ Tip sheets are useful but
insidious because it’s easy to rely on
them too much and not read the stories
in the rest of the journal. So it’s an
imperfect system.
Gitschier: What journals give you these
tip sheets?
Wade: A lot of journals do it now. I
look carefully at the Nature journals,
Science, PNAS [Proceedings of the National
Academy of Sciences], American Journal of
Human Genetics, and the Cell journals.
Gitschier: And PLoS, of course!
Wade: PLoS, of course!
Gitschier: Are you ever strong-armed
by anyone to write about his or her
work?
Wade: People sometimes do call up,
but not as much as I’d like. Scientists
are reticent about promoting their
work to the press because they risk
being criticized by their colleagues for
doing so. But sometimes people call to
say, ‘‘I’ve got something very exciting,’’
and send me the paper in advance. It’s
always very useful to hear from people
when they are enthusiastic about a
result.
Gitschier: Do you attend scientiﬁc
meetings?
Wade: Yes, I do, but not as many as I’d
like. When you go to a meeting, you’re
usually obligated to write a story about
it, and many scientiﬁc meetings are
very hard to write about for the general
reader because the ﬁndings are often
incremental advances and difﬁcult to
summarize. On the other hand,
meetings are very useful for talking to
people in person, so I try to go to as
many as I can.
Gitschier: After you read a paper,
what’s your next step?
Wade: I usually start by talking to the
authors, and then call others in the
ﬁeld to see if they share the author’s
interpretation of the ﬁnding. Much of
this can also be done with E-mail. I try
to keep talking with people until I feel I
understand a paper and its strengths
and weaknesses, and then I’m ready to
write it up.
Gitschier: Do you do most of your
writing at home?
Wade: It’s more restful to write at
home. But if I have a story that will
appear in the paper the next day, it’s
usually easier to be in the ofﬁce.
Gitschier: How many articles do you
write per week?
Wade: Usually about one or two, or
more if there’s lots of news. I’ve been
on book leave for much of this year.
Gitschier: What is your new book
about?
Wade: It’s on what genetics is telling us
about human evolution, human nature,
and prehistory. I’m trying to integrate
information from the many different
ﬁelds that bear on the human past—
paleoanthropology, archeology,
historical linguistics, and evolutionary
psychology—all of which are now being
informed and ampliﬁed by genetics.
Gitschier: Back to the process. What’s
next?
Wade: You have to sell a story to your
editor. It’s a quite small department, so
if a reporter says, ‘‘This is an important
subject,’’ it will probably go into the
paper. But the question is at what
length because space is at a premium.
The editors who run the main paper,
who tend to have a political/foreign
affairs background, may not be as
enthusiastic about science as we are.
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to assess how much space they are likely
to get for a story.
Gitschier: I want to learn more about
which stories you choose to develop.
When you look back on the stories that
you’ve written about over the past ﬁve
to six years, which ones leap out at you?
Wade: The ﬁrst that comes to mind is
the race to sequence the human
genome. It was a good science story, but
it was also of interest to general readers
because of the rivalry between Celera
and the university people.
Another story I found interesting was
the genetics of human dispersal. We’ve
had the picture of human origins as
developed by the paleoanthropologists,
andit’swonderfulhowwellthey’vedone
with the material they’ve had available
to them—just a handful of skulls. Then,
the geneticists arrived on the scene and
added a whole new dimension.
For example, there was a paper by
Mark Stoneking about when man ﬁrst
started to wear clothes. He managed to
ﬁgure out the date at which the human
body louse, which lives in clothing,
evolved from the human head louse,
which lives just in hair. And the date of
that divergence must give the time at
which humans ﬁrst started to wear
reasonably close-ﬁtting clothing. It’s
wonderful that genetics can provide
that quite surprising insight.
Gitschier: My favorite recent story is
Homo ﬂoresiensis.
Wade: Isn’t that nice! The referees took
a whole year, I think, to convince
themselves that this was real. They
started off by thinking this fossil must
be a pathological Homo sapiens skull, but
then realized it doesn’t look like sapiens,
so it must be erectus. But it was found
with artifacts just like those made by
modern humans. To assume the little
Floresians made these artifacts
contradicts almost everything that
paleoanthropologists have been taught:
that we didn’t start to make tools until
our brains were about twice the size of
chimpanzees’, which are approximately
the size of Homo ﬂoresiensis. This is such
a paradoxical ﬁnding!
I think the paleoanthropology
community is going through the same
learning process as the reviewers did.
They started with the assumption that
these were modern human artifacts and
a pathological skull, but eventually
came to accept that everything was the
work of a downsized erectus.
Gitschier: I like it when people are
forced to rethink their dogma! What
about the other side of the coin—
stories that you missed?
Wade: I think the main one in that
category is RNAi [RNA interference],
about which I’ve written only one story.
I kept thinking, ‘‘This is fascinating, but
the general reader won’t be interested
in the details of molecular biology, so
let’s wait till it advances more.’’ I think I
was far too late.
Another thing that is very difﬁcult for
sciencereporterstotackleisthefactthat
most scientiﬁc research ends nowhere.
People can be very enthusiastic about
what they are doing, but just as most
drugs fail in clinical trials, many
advancesthatseemverypromisingdon’t
lead anywhere. So after you have been
mistakena certainnumber of times,you
tendtobealittlecautious.Ofcourse,it’s
then very easy to become far more
skeptical than one should be.
Gitschier: Gene therapy, for example, is
a ﬁeld that many thought had promise.
It had some successes and some
spectacular failures.
Wade: That’saﬁeldthat’sbeengoingon
for about 15 years. And almost all the
coverage throughout the ﬁrst ten years
kept saying gene therapy is great. But in
retrospect, it was quite wrong—it wasn’t
great at all. There were technical
obstacles that have still not been
overcome. I think the lesson for
reporters is that they should not get too
caught up in scientists’ enthusiasm. It’s
ﬁnetoreportthatscientistsareenthused
about some new ﬁnding or project, but
reportersshouldremaindetachedabout
whether or not it will succeed.
Stem cells are a case in point. The
hidden premise of proposals for stem
cell therapy is that we needn’t
understand exactly what is going on
because if you just put the cells in the
right place they will know what to do.
My fear is that we need to understand
the total cell circuitry to get stem cells
to do anything useful, and that won’t
happen for years.
Gitschier: By choosing to write up
certain stories and ignoring others, you
are making judgments. Are there things
out there that you are not writing
about because you simply don’t agree
with them?
Wade: The only criteria that reporters
are trained to apply is ‘‘Is this news?’’
So it doesn’t matter if you agree with it
or not.
Gitschier: But is that the ethical thing
to do?
Wade: If someone makes a newsworthy
claim that I suspect is not true, I will try
to see if there are skeptics and expose
readers to both sides of the issue. A
reporter’s job is to give readers
sufﬁcient information to make up their
own minds. In a news story, you should
expose people to all the possibilities,
but you don’t have to decide which one
is correct. The hard thing about writing
editorials is that you have to decide.
Gitschier: It’s such a responsibility, I
would think.
Wade: If you try to ﬁgure out the
consequences of every article, you’d
never write anything.
Gitschier: Returning then to the
question of editorial writing, what were
some of the memorable topics that you
had to write about?
Wade: There weren’t that many
scientiﬁc issues about which we could
have an editorial opinion, since many
issues in science are a matter of
ascertainable fact, not opinion.
I was writing editorials during the
Reagan administration, so there were
many environmental issues to inveigh
about, inspired by the likes of Ann
Gorsuch and James Watt. During the
Reagan military buildup, I also wrote
manyeditorialsaboutmilitaryhardware
and procurement scandals. I remember
having great difﬁculty making up my
mind about a ‘‘big science’’ project dear
to physicists, the superconducting
supercollider. I wrote one editorial in
favor of it, the next year one against it,
and the third year one in the middle.
Editorial writers have to do their
learninginpublic,oratleastIdid.Lifeis
much easier once you have developed
your position on the issues.
Gitschier: Today, there would seem to
be a lot of opportunities for editorial
writing in genetics—embryonic stem
cells, cloning, reproductive choices,
and intelligent design, to name a few.
Wade: I think you’re right. Of course,
stem cells would be less of an issue if
the government hadn’t tried to restrict
the research. Intelligent design is a
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I think, for the science section because
it has no scientiﬁc content. It’s a debate
that was settled in the 19th century. It’s
not our role to educate people, and I
see no more reason to discuss whether
intelligent design is an alternative to
evolution than to discuss whether or
not the earth is ﬂat.
Gitschier: What about the urgency to
write things?
Wade: There is nothing like a deadline
for concentrating your mind. Some of
the hardest stories are when you are
asked to get a story at very short notice,
such as late at night when the editors
see the Washington Post has some story,
and ask you to match it. If you don’t
have the home numbers of the people
you need to talk to, you’re out of luck.
Most reporters know their beat well
enough that they can match a story at
short notice. Fortunately, it doesn’t
happen too often.
Gitschier: One of the things I like about
my job as a geneticist is that there is
always something new on the horizon.
You must feel the same way.
Wade: Yes, and journalists have the
luxury of being able to move from one
ﬁeld to another. If it’s a slow week in
genetics, I can write about cognitive
science.
If you’re not learning something new
every day, you have no one but yourself
to blame. &
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